Divis Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)
Divis Laboratories Ltd · Outcome · 07 Nov 2026, 5:26 pm
Divis Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 3,676 (+35.4% YoY | +19.4% QoQ) ■ EBITDA: 1,566 (+76.4% YoY | +24.8% QoQ) ■ EBITDA Margin (%): 42.6 (+989 bps YoY | +185 bps QoQ) ■ PAT: 1,127 (+63.6% YoY | +24.9% QoQ) ■ EPS (INR): 42.5 (+63.6% YoY | +25.2% QoQ)
Original exchange filing (PDF)
More announcements from Divis Laboratories Ltd
- submission of transcript of Q2Fy27 earnings call held on November 07, 2026. · 13 Nov 2026
- Intimation of audio link of Q2FY26 earnings call held on 07.11.2026. · 07 Nov 2026
- As per enclosed. · 07 Nov 2026
- As enclosed. · 07 Nov 2026
- Intimation of schedule of Q2FY2027 earnings call to be held on November 07, 2026 at 14:00 Hrs (IST). · 07 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 07 Nov 2026
- Divi's Laboratories Limited has informed the Exchange about Board Meeting to be held on 07-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 07 Nov 2026
- Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve unaudited financial results .... · 07 Nov 2026
